AURKA and prostate carcinoma: In contrast, AURKA transcripts were upregulated in only 15.4% of prostate cancer (PCa) and 76.3% of BPH specimens [2], indicating that post-translational stabilization of AURKA is a critical factor in promoting its deregulation.